Delta sleep-inducing peptide (DSIP) appears to interact with the dopaminergic system, influencing thermoregulatory mechanisms and potentially modulating neurotransmitter levels such as serotonin (5-HT), glutamate, and dopamine. Its exact mechanism of action remains poorly characterized, with no specific receptors or signaling pathways definitively identified, although it may involve interactions with the pineal gland and influence on sleep regulation. Additionally, DSIP has shown potential neuroprotective effects during ischemia-reperfusion injuries, suggesting involvement in cellular stress response pathways, but further elucidation of its biological activity is needed.